Global Overactive Bladder Treatment Market Research Report 2023

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.

The global Overactive Bladder Treatment market was valued at US$ 5266 million in 2022 and is anticipated to reach US$ 6287.9 million by 2029, witnessing a CAGR of 3.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Overactive Bladder Treatment key players include Allergan, Astellas Pharma, Pfizer, Johnson & Johnson, Medtronic, etc. Global top five manufacturers hold a share about 90%. United States is the largest market, with a share about 60%, followed by Europe, with a share about 15 percent. In terms of product, Drugs is the largest segment, with a share about 95%. And in terms of application, the largest application is Idiopathic Overactive Bladder, followed by Neurogenic Overactive Bladder.

This report aims to provide a comprehensive presentation of the global market for Overactive Bladder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Overactive Bladder Treatment.

The Overactive Bladder Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Overactive Bladder Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Overactive Bladder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Overactive Bladder Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Drugs

1.2.3 Device

1.3 Market by Application

1.3.1 Global Overactive Bladder Treatment Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Idiopathic Overactive Bladder

1.3.3 Neurogenic Overactive Bladder

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Overactive Bladder Treatment Market Perspective (2018-2029)

2.2 Overactive Bladder Treatment Growth Trends by Region

2.2.1 Global Overactive Bladder Treatment Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Overactive Bladder Treatment Historic Market Size by Region (2018-2023)

2.2.3 Overactive Bladder Treatment Forecasted Market Size by Region (2024-2029)

2.3 Overactive Bladder Treatment Market Dynamics

2.3.1 Overactive Bladder Treatment Industry Trends

2.3.2 Overactive Bladder Treatment Market Drivers

2.3.3 Overactive Bladder Treatment Market Challenges

2.3.4 Overactive Bladder Treatment Market Restraints

3.1 Global Top Overactive Bladder Treatment Players by Revenue

3.1.1 Global Top Overactive Bladder Treatment Players by Revenue (2018-2023)

3.1.2 Global Overactive Bladder Treatment Revenue Market Share by Players (2018-2023)

3.2 Global Overactive Bladder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Overactive Bladder Treatment Revenue

3.4 Global Overactive Bladder Treatment Market Concentration Ratio

3.4.1 Global Overactive Bladder Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Overactive Bladder Treatment Revenue in 2022

3.5 Overactive Bladder Treatment Key Players Head office and Area Served

3.6 Key Players Overactive Bladder Treatment Product Solution and Service

3.7 Date of Enter into Overactive Bladder Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Overactive Bladder Treatment Historic Market Size by Type (2018-2023)

4.2 Global Overactive Bladder Treatment Forecasted Market Size by Type (2024-2029)

5.1 Global Overactive Bladder Treatment Historic Market Size by Application (2018-2023)

5.2 Global Overactive Bladder Treatment Forecasted Market Size by Application (2024-2029)

6.1 North America Overactive Bladder Treatment Market Size (2018-2029)

6.2 North America Overactive Bladder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Overactive Bladder Treatment Market Size by Country (2018-2023)

6.4 North America Overactive Bladder Treatment Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Overactive Bladder Treatment Market Size (2018-2029)

7.2 Europe Overactive Bladder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Overactive Bladder Treatment Market Size by Country (2018-2023)

7.4 Europe Overactive Bladder Treatment Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Overactive Bladder Treatment Market Size (2018-2029)

8.2 Asia-Pacific Overactive Bladder Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Overactive Bladder Treatment Market Size by Region (2018-2023)

8.4 Asia-Pacific Overactive Bladder Treatment Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Overactive Bladder Treatment Market Size (2018-2029)

9.2 Latin America Overactive Bladder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Overactive Bladder Treatment Market Size by Country (2018-2023)

9.4 Latin America Overactive Bladder Treatment Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Overactive Bladder Treatment Market Size (2018-2029)

10.2 Middle East & Africa Overactive Bladder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Overactive Bladder Treatment Market Size by Country (2018-2023)

10.4 Middle East & Africa Overactive Bladder Treatment Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Allergan

11.1.1 Allergan Company Detail

11.1.2 Allergan Business Overview

11.1.3 Allergan Overactive Bladder Treatment Introduction

11.1.4 Allergan Revenue in Overactive Bladder Treatment Business (2018-2023)

11.1.5 Allergan Recent Development

11.2 Astellas Pharma

11.2.1 Astellas Pharma Company Detail

11.2.2 Astellas Pharma Business Overview

11.2.3 Astellas Pharma Overactive Bladder Treatment Introduction

11.2.4 Astellas Pharma Revenue in Overactive Bladder Treatment Business (2018-2023)

11.2.5 Astellas Pharma Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Detail

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Overactive Bladder Treatment Introduction

11.3.4 Pfizer Revenue in Overactive Bladder Treatment Business (2018-2023)

11.3.5 Pfizer Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Detail

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Overactive Bladder Treatment Introduction

11.4.4 Johnson & Johnson Revenue in Overactive Bladder Treatment Business (2018-2023)

11.4.5 Johnson & Johnson Recent Development

11.5 Medtronic

11.5.1 Medtronic Company Detail

11.5.2 Medtronic Business Overview

11.5.3 Medtronic Overactive Bladder Treatment Introduction

11.5.4 Medtronic Revenue in Overactive Bladder Treatment Business (2018-2023)

11.5.5 Medtronic Recent Development

11.6 KYORIN Pharmaceutical

11.6.1 KYORIN Pharmaceutical Company Detail

11.6.2 KYORIN Pharmaceutical Business Overview

11.6.3 KYORIN Pharmaceutical Overactive Bladder Treatment Introduction

11.6.4 KYORIN Pharmaceutical Revenue in Overactive Bladder Treatment Business (2018-2023)

11.6.5 KYORIN Pharmaceutical Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Overactive Bladder Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Drugs

    Table 3. Key Players of Device

    Table 4. Global Overactive Bladder Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Overactive Bladder Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Overactive Bladder Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Overactive Bladder Treatment Market Share by Region (2018-2023)

    Table 8. Global Overactive Bladder Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Overactive Bladder Treatment Market Share by Region (2024-2029)

    Table 10. Overactive Bladder Treatment Market Trends

    Table 11. Overactive Bladder Treatment Market Drivers

    Table 12. Overactive Bladder Treatment Market Challenges

    Table 13. Overactive Bladder Treatment Market Restraints

    Table 14. Global Overactive Bladder Treatment Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Overactive Bladder Treatment Market Share by Players (2018-2023)

    Table 16. Global Top Overactive Bladder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder Treatment as of 2022)

    Table 17. Ranking of Global Top Overactive Bladder Treatment Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Overactive Bladder Treatment Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Overactive Bladder Treatment Product Solution and Service

    Table 21. Date of Enter into Overactive Bladder Treatment Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Overactive Bladder Treatment Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Overactive Bladder Treatment Revenue Market Share by Type (2018-2023)

    Table 25. Global Overactive Bladder Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Overactive Bladder Treatment Revenue Market Share by Type (2024-2029)

    Table 27. Global Overactive Bladder Treatment Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Overactive Bladder Treatment Revenue Market Share by Application (2018-2023)

    Table 29. Global Overactive Bladder Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Overactive Bladder Treatment Revenue Market Share by Application (2024-2029)

    Table 31. North America Overactive Bladder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Overactive Bladder Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Overactive Bladder Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Overactive Bladder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Overactive Bladder Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Overactive Bladder Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Overactive Bladder Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Overactive Bladder Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Overactive Bladder Treatment Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Overactive Bladder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Overactive Bladder Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Overactive Bladder Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Overactive Bladder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Overactive Bladder Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Overactive Bladder Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Allergan Company Detail

    Table 47. Allergan Business Overview

    Table 48. Allergan Overactive Bladder Treatment Product

    Table 49. Allergan Revenue in Overactive Bladder Treatment Business (2018-2023) & (US$ Million)

    Table 50. Allergan Recent Development

    Table 51. Astellas Pharma Company Detail

    Table 52. Astellas Pharma Business Overview

    Table 53. Astellas Pharma Overactive Bladder Treatment Product

    Table 54. Astellas Pharma Revenue in Overactive Bladder Treatment Business (2018-2023) & (US$ Million)

    Table 55. Astellas Pharma Recent Development

    Table 56. Pfizer Company Detail

    Table 57. Pfizer Business Overview

    Table 58. Pfizer Overactive Bladder Treatment Product

    Table 59. Pfizer Revenue in Overactive Bladder Treatment Business (2018-2023) & (US$ Million)

    Table 60. Pfizer Recent Development

    Table 61. Johnson & Johnson Company Detail

    Table 62. Johnson & Johnson Business Overview

    Table 63. Johnson & Johnson Overactive Bladder Treatment Product

    Table 64. Johnson & Johnson Revenue in Overactive Bladder Treatment Business (2018-2023) & (US$ Million)

    Table 65. Johnson & Johnson Recent Development

    Table 66. Medtronic Company Detail

    Table 67. Medtronic Business Overview

    Table 68. Medtronic Overactive Bladder Treatment Product

    Table 69. Medtronic Revenue in Overactive Bladder Treatment Business (2018-2023) & (US$ Million)

    Table 70. Medtronic Recent Development

    Table 71. KYORIN Pharmaceutical Company Detail

    Table 72. KYORIN Pharmaceutical Business Overview

    Table 73. KYORIN Pharmaceutical Overactive Bladder Treatment Product

    Table 74. KYORIN Pharmaceutical Revenue in Overactive Bladder Treatment Business (2018-2023) & (US$ Million)

    Table 75. KYORIN Pharmaceutical Recent Development

    Table 76. Research Programs/Design for This Report

    Table 77. Key Data Information from Secondary Sources

    Table 78. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Overactive Bladder Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Overactive Bladder Treatment Market Share by Type: 2022 VS 2029

    Figure 3. Drugs Features

    Figure 4. Device Features

    Figure 5. Global Overactive Bladder Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Overactive Bladder Treatment Market Share by Application: 2022 VS 2029

    Figure 7. Idiopathic Overactive Bladder Case Studies

    Figure 8. Neurogenic Overactive Bladder Case Studies

    Figure 9. Overactive Bladder Treatment Report Years Considered

    Figure 10. Global Overactive Bladder Treatment Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 11. Global Overactive Bladder Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Overactive Bladder Treatment Market Share by Region: 2022 VS 2029

    Figure 13. Global Overactive Bladder Treatment Market Share by Players in 2022

    Figure 14. Global Top Overactive Bladder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder Treatment as of 2022)

    Figure 15. The Top 10 and 5 Players Market Share by Overactive Bladder Treatment Revenue in 2022

    Figure 16. North America Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 17. North America Overactive Bladder Treatment Market Share by Country (2018-2029)

    Figure 18. United States Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. Canada Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Europe Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Overactive Bladder Treatment Market Share by Country (2018-2029)

    Figure 22. Germany Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. France Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. U.K. Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Italy Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Russia Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Nordic Countries Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Asia-Pacific Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Overactive Bladder Treatment Market Share by Region (2018-2029)

    Figure 30. China Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Japan Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. South Korea Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Southeast Asia Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. India Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Australia Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Latin America Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Overactive Bladder Treatment Market Share by Country (2018-2029)

    Figure 38. Mexico Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Brazil Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Middle East & Africa Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Overactive Bladder Treatment Market Share by Country (2018-2029)

    Figure 42. Turkey Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Saudi Arabia Overactive Bladder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Allergan Revenue Growth Rate in Overactive Bladder Treatment Business (2018-2023)

    Figure 45. Astellas Pharma Revenue Growth Rate in Overactive Bladder Treatment Business (2018-2023)

    Figure 46. Pfizer Revenue Growth Rate in Overactive Bladder Treatment Business (2018-2023)

    Figure 47. Johnson & Johnson Revenue Growth Rate in Overactive Bladder Treatment Business (2018-2023)

    Figure 48. Medtronic Revenue Growth Rate in Overactive Bladder Treatment Business (2018-2023)

    Figure 49. KYORIN Pharmaceutical Revenue Growth Rate in Overactive Bladder Treatment Business (2018-2023)

    Figure 50. Bottom-up and Top-down Approaches for This Report

    Figure 51. Data Triangulation

    Figure 52. Key Executives Interviewed